Optimi Health Corp.

OPTH chart

Optimi Health Corp. news

• Ex-BMS exec wins Aussie Country Lead role

  Pharma in Focus · Oct 27, 12:03 AM EDT

• Optimi Health Corp. (OPTI.CN) Stock Price, News, Quote & History

  Yahoo! Finance Canada · Oct 26, 11:47 PM EDT

• Equillium Announces First Subject Dosed in Phase 1 Clinical Trial of EQ504

  Yahoo! Finance Canada · Oct 26, 8:30 AM EDT

• Optimi Health Establishes Optimi Australia Pty Ltd as Dedicated Distribution and Business Development Entity

  Yahoo Finance · Oct 26, 8:00 AM EDT

• Optimi Health Completes MDMA Production for Phase 3 PTSD Trial in Canada, MAPS Trial in Israel and Commercial Supply in Australia

  Yahoo Finance · Oct 20, 8:30 AM EDT

• Optimi Health to Present at the ThinkEquity Conference

  Yahoo Finance · Oct 7, 9:00 AM EDT

• Optimi Health Appoints Melanie Pump to Board of Directors

  Yahoo Finance · Sep 29, 7:30 AM EDT

• Optimi Health Completes Psilocybin Production for Phase 2 MDD Trial

  Yahoo Finance · Sep 23, 11:58 AM EDT

• Optimi Health Completes Psilocybin Production for Health Canada-Approved Phase 2 MDD Trial and Commercial TRD Supply

  Yahoo Finance · Sep 23, 9:00 AM EDT

• Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer

  Yahoo Finance · Sep 22, 9:00 AM EDT

• Weekly Roundup on the Cannabis Sector & Psychedelic Sector

  Yahoo Finance · Sep 21, 11:01 AM EDT

• Elon Musk Once Said Psychedelics Could Help PTSD — Now FDA Holds Hearing as Optimi Health Advances MDMA Trial

  Yahoo Finance · Sep 18, 8:30 PM EDT

Optimi Health Corp. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KFORM 6-K2026-10-26
• 6-KFORM 6-K2026-10-20
• 6-KFORM 6-K2026-10-07
• 6-KFORM 6-K2026-09-29
• 6-KFORM 6-K2026-09-23
• 6-KFORM 6-K2026-09-22
• 6-KFORM 6-K2026-09-16
• 6-KFORM 6-K2026-09-10
• 6-KFORM 6-K2026-09-08
• 6-KFORM 6-K2026-08-27
• 6-KCURRENT REPORT2026-08-14
• 6-KFORM 6-K2026-08-14

About Optimi Health Corp.

Ticker

OPTH (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Vancouver, British Columbia, Canada

Incorporated in

British Columbia, Canada

Fiscal year end

September 30

SEC CIK

2027329

Frequently asked questions